Key Academic Merits

• 2012-present – 50 % Senior scientist in collaboration with Matti Poutanen’s group, Institute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, University of Turku, Finland
• 2017-present – 50 % Teaching in the study programs of Medicine and Biomedicine, University of Turku, Finland
• 2013-2015 – 50 % Senior Scientist in Forendo Pharma Ltd, Turku, Finland
• 2010-2012 – Alexander von Humboldt postdoctoral fellow in collaboration with Marina Schorpp-Kistner’s group, German Cancer Research Center, Heidelberg, Germany
• Supervisor of 3 master students and 2 bachelor students
• Member of the Cell Culture Core facility at the Institute of Biomedicine
• Member and auditor of The Finnish Physiological Society
• Member of The Finnish Endocrine Society
• Ad hoc referee in international scientific journals and grant calls

Major Funding

The Emil Aaltonen’s foundation, The Turku University foundation, The South-West Finland Cancer Association

Selected Publications

Gabriel M*, Fey V*, Heinosalo T*, Adhikari P, Rytkönen K, Komulainen T, Huhtinen K, Laajala TD, Siitari H, Virkki A, Suvitie P, Kujari H, Aittokallio T, Perheentupa A, Poutanen M: A relational database to identify differentially expressed genes in the endometrium and endometriosis lesions. Sci data 2020, 7:284. * Equal contribution.

Rytkönen K, Heinosalo T, Mahmoudian M, Ma X, Perheentupa A, Elo L, Poutanen M, Wagner GP: Transcriptomic responses to hypoxia in endometrial and decidual stromal cells. Reproduction. 2020 Jul;160(1):39-51.

Kettunen K, Boström P, Lamminen T, Heinosalo T, West G, Kaipio K, Albanese C, Poutanen M, Rantala J, Taimen P: High-throughput drug screening using conditionally reprogrammed patient-derived bladder cancer cell lines. Eur Urol. 2019;76(4):430–434.

Heinosalo T, Saarinen N, Poutanen M: Preclinical models validating the role for Hydroxysteroid (17beta) dehydrogenase type 1 in human diseases. Mol Cell Endocrinol. 2019 Jun 1;489:9-31

Järvensivu P*, Heinosalo T*, Hakkarainen J, Kronqvist P, Saarinen N, Poutanen M: HSD17B1 expression induces inflammation-aided rupture of mammary gland myoepithelium: Endocr Relat Cancer. 2018 Apr;25(4):393-406. *Equal contribution.

Heinosalo T*, Gabriel M*, Kallio L, Adhikari P, Huhtinen K, Laajala D, Kaikkonen E, Mehmood A, Suvitie P, Kujari H, Aittokallio T, Perheentupa A, Poutanen M: Human SFRP2 marks endometriosis lesion borders and acts as a canonical WNT signaling agonist promoting proliferation of endometriosis lesions. *Equal contribution. Hum Reprod 2018 May 1;33(5):817-831